Skip to main content
Clinical Trials/NCT03499314
NCT03499314CompletedNot Applicable

A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)

NYU Langone Health1 site in 1 country65 target enrollmentStarted: April 15, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
65
Locations
1
Primary Endpoint
Mean Preload Phase Duration (PLD)

Study Overview

Brief Summary

This is a randomized, double-blind pilot clinical trial to test a novel treatment approach to rehabilitate fine motor function in individuals living with progressive multiple sclerosis (MS) using anodal transcranial direct current stimulation (tDCS) to augment manual dexterity training. Treatment will be delivered to individuals at home using a state-of-the-art remotely supervised tele-rehabilitation protocol, a major advantage for patients with respect to ease of access, feasibility, reinforcement learning and minimal burden of in clinic study visit participation. Improvements in fine motor skill will be assessed at each remote session using a novel portable grip device that measures execution and adaptation or learning of fingertip forces during grasp, which is more sensitive than standard measures of hand function.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Definite MS diagnosis, progressive subtype
  • 9HPT score between -1.0 and -4.0 standard deviations from age-based normative data
  • Score of < 7.5 or less on the EDSS (with caregiver proxy required for those with scores of 6.5 or greater)*
  • Ability to understand the informed consent process and provide consent to participate in the study

Exclusion Criteria

  • Primary neurologic, psychiatric or other medical disorder other than MS
  • Use of upper extremity Botox injection within 3 months
  • Current use of intrathecal Baclofen
  • History of seizure disorder
  • History of head trauma or medical device in head or neck
  • Clinically significant abnormality on EKG
  • Symbol Digit Modalities Test or SDMT score ≥3.0 SD from published norms
  • WRAT-4 reading level below average (<85) (estimated general intellectual function)
  • Skin disorder/sensitive near stimulation locations

Arms & Interventions

RS-tDCS Stimulation

Experimental

20 times 20 minute stimulation session supervised by a study technician through a videoconferencing platform, VSee

Intervention: Active RS-tDCS +At-Home Manual Dexterity Training (Device)

RS-tDCS Stimulation

Experimental

20 times 20 minute stimulation session supervised by a study technician through a videoconferencing platform, VSee

Intervention: Manual dexterity training (Other)

Sham Stimulation

Placebo Comparator

20 ×20-minute sessions sham tDCS

Intervention: Sham RS-tDCS +At-Home Manual Dexterity Training (Device)

Sham Stimulation

Placebo Comparator

20 ×20-minute sessions sham tDCS

Intervention: Manual dexterity training (Other)

Outcomes

Primary Outcomes

Mean Preload Phase Duration (PLD)

Time Frame: baseline and 30 minutes for each of 20 sessions, values averaged across sessions

(PLD) is the duration of finger contact until the onset of positive load force. It assesses the time taken to stabilize grasp and is a robust measure of grasp execution.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials